compound vastly differs from current drug therapies because it does not specifically target any one virus; instead it is directed at the human immune system to fortify its response. It... from the prevailing approach of existing therapies that are developed to target a single virus. The standard method has become less effective because viruses are so highly adept...

present therapies, less toxic and less likely to cause viral mutation that leads to more dangerous drug resistant strains Kineta scientists are also utilizing the RIG-I platform...

-suppressive Designed to reduce inflammation, tissue destruction and restore normal immune function Improved tolerability and efficacy as compared with existing therapies Synthetic...

Development of a Sea Anemone Toxin as an Immunomodulator for Therapy of Autoimmune Diseases. Chi, Victor, Michael W. Pennington, Raymond S. Norton, Eric J. Tarcha, Luz M. Londono...):11094-9. PMID: 16043714 Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Beeton C, Pennington MW, Wulff H...

Therapeutics, a company focused on new cancer therapies. In 2012 he accepted an invitation to serve as Entrepreneur-in-Residence at the University of Washington. He works with staff...